This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Syngenta Participations Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Andrew DeBrecht
Introduction
Andrew DeBrecht is an accomplished inventor based in Cary, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase polypeptides. His work has implications for agricultural practices and plant biology.
Latest Patents
DeBrecht holds a patent for the "Truncation of the C-terminal end of alpha-amylase." This invention focuses on C-terminal truncated α-amylase polypeptides, along with the nucleic acid sequences that encode these polypeptides. The methods associated with this invention enhance the accumulation and secretion of biologically-active α-amylase in plant cells, compared to the full-length version of the enzyme.
Career Highlights
Andrew DeBrecht is currently employed at Syngenta Participations AG, a leading company in agricultural science. His work at Syngenta has allowed him to explore innovative solutions that improve crop yield and efficiency. His research is pivotal in advancing the understanding of enzyme functions in plants.
Collaborations
DeBrecht collaborates with notable colleagues such as Aron Silverstone and Yan Zhang. These partnerships enhance the research and development efforts at Syngenta, fostering a collaborative environment that drives innovation.
Conclusion
Andrew DeBrecht's contributions to biotechnology through his patent on alpha-amylase polypeptides exemplify the impact of innovative research in agriculture. His work continues to influence the field and improve agricultural practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile